Share on Pinterest The newly approved drug could save thousands of lives in the U.K. alone. Coolpicture/Getty Images About half of the U.K.’s adult population currently has cholesterol levels above ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication for inclisiran to include patients with high LDL but without a history ...
WASHINGTON, DC — Treatment with inclisiran (Alnylam Pharmaceuticals/the Medicines Company), which suppresses proprotein convertase subtilisin-kexin type 9 (PCSK9) synthesis in the liver, can ...
More patients with hypercholesterolemia at high/very high risk of cardiovascular (CV) events achieved low-density lipoprotein cholesterol (LDL-C) goals with inclisiran compared with placebo, when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results